Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Crystal Structure Of Phenylmethanesulfonyl Fluoride-treated Human Chymase At 1.9 A.

M. Mcgrath, T. Mirzadegan, B. Schmidt
Published 1997 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The X-ray crystal structure of human chymase has been determined to 1.9 A resolution using molecular replacement methods. This first structure of human chymase is present as the Ser 195 ester of alpha-toluenesulfonic acid. The refined structure (Rcryst = 0.183) shows that the inhibitor phenyl moiety lies at the top of the major specificity pocket, S1, while the sulfur is covalently linked to Ser 195-O gamma. The sulfonyl oxygens interact with the oxyanion hole and with His 57-N delta 1. The presence of the inhibitor disturbs the usual gauche position of His 57 and forces it to the trans conformer. Though the primary binding pockets are similarly specific in chymase and chymotrypsin, examination of the extended substrate binding sites reveals the structural basis for chymase's greater discrimination in choosing substrates. The larger 30s loop and its proximity to the active site indicates that it contacts substrate residues C-terminal to the scissile bond. Modeling of substrate at the chymase active site suggests that binding energy may be gained by three main-chain hydrogen bonds provided by substrate residues P2' and P4' and that discriminating interactions with substrate side chains are also likely. The presence of Lys 40 in S1' of human chymase explains its preference for Asp/Glu at P1'. Moreover, the cationic nature of S1' provides a structural basis for human chymase's poor catalytic efficiency when angiotensin II is the substrate.



This paper is referenced by
10.1517/13543776.9.11.1537
Inhibitors of human mast cell serine proteases and potential therapeutic applications
Kenneth D. Rice (1999)
10.1016/S0960-894X(99)00377-7
Human chymase inhibitors based on the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold.
W. Groutas (1999)
10.1111/j.1742-4658.2011.08189.x
Discriminating between the activities of human cathepsin G and chymase using fluorogenic substrates
B. Korkmaz (2011)
10.1021/ci300550a
Cavities Tell More than Sequences: Exploring Functional Relationships of Proteases via Binding Pockets
Serghei Glinca (2013)
10.1016/S0167-4838(99)00265-4
The human mast cell tryptase tetramer: a fascinating riddle solved by structure.
C. Sommerhoff (2000)
10.1074/JBC.M400949200
Characterization of Structural Determinants of Granzyme B Reveals Potent Mediators of Extended Substrate Specificity*
S. W. Ruggles (2004)
10.1016/S0968-0896(00)00310-2
Inhibition of human chymase by 2-amino-3,1-benzoxazin-4-ones.
U. Neumann (2001)
10.1134/S0006297910070072
Recombinant maize 9-lipoxygenase: Expression, purification, and properties
E. Osipova (2010)
10.1006/BBRC.2001.4858
Inhibitory mechanism of daphnodorins for human chymase.
M. Sakaguchi (2001)
10.1016/S0065-2776(07)95006-3
Mast cell proteases.
G. Pejler (2007)
10.1016/B978-012473335-0/50020-9
Chapter 18 – Structure and Function of Human Chymase
N. Schechter (2000)
10.1371/journal.pone.0062740
Molecular Modeling Study for Inhibition Mechanism of Human Chymase and Its Application in Inhibitor Design
M. Arooj (2013)
10.1093/intimm/dxn128
The extended substrate specificity of the human mast cell chymase reveals a serine protease with well-defined substrate recognition profile.
M. Andersson (2009)
10.1016/j.bcp.2010.06.014
Potency variation of small-molecule chymase inhibitors across species.
J. Kervinen (2010)
10.1016/J.BPC.2007.10.001
Thermal aggregation of α-chymotrypsin : Role of hydrophobic and electrostatic interactions
N. Rezaei-Ghaleh (2008)
10.1016/S1097-2765(03)00308-3
A despecialization step underlying evolution of a family of serine proteases.
M. A. Wouters (2003)
10.1074/JBC.M207962200
The 2.2-Å Crystal Structure of Human Pro-granzyme K Reveals a Rigid Zymogen with Unusual Features*
C. Hink-Schauer (2002)
Hematopoietic Serine Proteases from the Mast Cell Chymase and Tryptase Loci - a Functional and Evolutionary Analysis
J. Reimer (2008)
10.1107/S174430911001434X
The structure of PhaZ7 at atomic (1.2 A) resolution reveals details of the active site and suggests a substrate-binding mode.
Sachin Wakadkar (2010)
10.1097/00005344-200205000-00002
Molecular Cloning and Sequencing of the cDNA for Rat Mesenteric Arterial Bed Elastase-2, an Angiotensin II–Forming Enzyme
C. Santos (2002)
10.1016/S0167-4838(00)00076-5
Angiotensin II generation by mast cell α- and β-chymases
G. Caughey (2000)
10.1074/jbc.274.20.13810
New, Sensitive Fluorogenic Substrates for Human Cathepsin G Based on the Sequence of Serpin-reactive Site Loops*
S. Réhault (1999)
10.1107/S0909049513020748
Crystal structure of a complex of human chymase with its benzimidazole derived inhibitor
Y. Matsumoto (2013)
10.1515/BC.2000.148
Crystal Structure of the Caspase Activator Human Granzyme B, a Proteinase Highly Specific for an Asp-P1 Residue
Eva Estébanez-Perpiñá (2000)
10.1016/j.jmgm.2019.03.011
Structure-based virtual screening for novel chymase inhibitors by in silico fragment mapping.
Shin-ichiro Ozawa (2019)
10.1046/J.1432-1327.1999.00160.X
Structural and energetic determinants of the S1-site specificity in serine proteases.
H. Czapinska (1999)
10.1142/9789812778406_0014
Conclusions: Future Perspectives
H. Nakamura (2002)
10.1016/S0167-4838(02)00224-8
Lys40 but not Arg143 influences selectivity of angiotensin conversion by human α-chymase
D. Muilenburg (2002)
10.2174/157339806778019024
A Pulmonary Perspective on GASPIDs: Granule-Associated Serine Peptidases of Immune Defense.
G. Caughey (2006)
10.1016/J.BBAPAP.2004.09.005
Serine proteases and cardiac function.
Q. Wu (2005)
Crystallographic analysis of Escherichia coli type I signal peptidase in complex with peptide-based inhibitors
C. Luo (2007)
10.1016/B978-0-12-382219-2.00590-1
Chapter 590 – Chymases
G. Caughey (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar